Literature DB >> 8765693

Immunotoxicology of T cell-dependent experimental liver injury.

G Tiegs1, F Gantner.   

Abstract

Microbial toxins as well as certain drugs and xenobiotics exert their toxic potential towards mammalian organisms by either activation or suppression of the immune system. We have investigated the immune stimulatory effect of either the bacterial superantigen staphylococcal enterotoxin B (SEB) or of the T cell activating anti-CD3 monoclonal antibody (alpha CD3-mAb) or of the T cell mitogenic plant lectin concanavalin A (Con A) in murine in vivo and in vitro systems. Any of these agents evoked a strong cytokine response in vitro and in vivo. Tumor necrosis factor-alpha (TNF) was identified as a common cytotoxic mediator which induced hepatocyte apoptosis as characterized by histological examination and internucleosomal DNA fragmentation, that preceded the release of liver specific enzymes into plasma and the histological appearance of necrosis. These mechanisms of acute liver failure observed under experimental conditions are discussed to account also for liver injury during acute episodes of autoimmune or viral hepatitis or rejection of liver grafts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8765693     DOI: 10.1016/S0940-2993(96)80058-3

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  10 in total

Review 1.  Animal models of acute hepatic failure.

Authors:  T M Rahman; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.

Authors:  S Jouan-Lanhouet; M I Arshad; C Piquet-Pellorce; C Martin-Chouly; G Le Moigne-Muller; F Van Herreweghe; N Takahashi; O Sergent; D Lagadic-Gossmann; P Vandenabeele; M Samson; M-T Dimanche-Boitrel
Journal:  Cell Death Differ       Date:  2012-07-20       Impact factor: 15.828

3.  Kupffer cell-dependent hepatitis occurs during influenza infection.

Authors:  Noelle K Polakos; Judith C Cornejo; Debbie A Murray; Kate O Wright; John J Treanor; I Nicholas Crispe; David J Topham; Robert H Pierce
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

4.  Hepatocyte-protective and anti-oxidant effects of rifampicin on human chronic hepatitis C and murine acute hepatocyte disorder.

Authors:  Kazuhiro Kataoka; Yutaka Kono; Masanobu Sugimoto; Yasuhiro Furuichi; Masayoshi Shichiri; Yujiro Tanaka
Journal:  Exp Ther Med       Date:  2010-09-29       Impact factor: 2.447

Review 5.  Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis.

Authors:  Chia-Ling Chen; Po-Chun Tseng; Rahmat Dani Satria; Thi Thuy Nguyen; Cheng-Chieh Tsai; Chiou-Feng Lin
Journal:  Int J Mol Sci       Date:  2022-04-23       Impact factor: 6.208

6.  Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol.

Authors:  Min Li; Geng-Tao Liu
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

7.  How T-cell-dependent and -independent challenges access the brain: vascular and neural responses to bacterial lipopolysaccharide and staphylococcal enterotoxin B.

Authors:  Jordi Serrats; Paul E Sawchenko
Journal:  Brain Behav Immun       Date:  2009-06-12       Impact factor: 7.217

8.  Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.

Authors:  Aaron M Fullerton; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Sci       Date:  2013-08-22       Impact factor: 4.849

9.  Quantitative Proteomic Analysis Reveals That Arctigenin Alleviates Concanavalin A-Induced Hepatitis Through Suppressing Immune System and Regulating Autophagy.

Authors:  Qin Feng; Jingchun Yao; Ge Zhou; Wenkai Xia; Jingang Lyu; Xin Li; Tao Zhao; Guimin Zhang; Ningwei Zhao; Jie Yang
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

Review 10.  Chronic liver disease: current concepts of disease mechanisms.

Authors:  S A Center
Journal:  J Small Anim Pract       Date:  1999-03       Impact factor: 1.522

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.